Objective @#To analyze the
survival of
patients with
malignant mesothelioma, so as to provide insights into the management of
malignant mesothelioma.@*
Methods @#Totally 36
patients with
malignant mesothelioma admitted to Cixi Third People’s
Hospital from October 2012 to January 2021 were enrolled, and the demographic features, exposure to
asbestos, and
diagnosis and
treatment were retrospectively reviewed. The
survival rate and median
survival time were calculated with the
life-table
method, and the factors affecting the
survival rate of
malignant mesothelioma were identified using the
Kaplan-Meier estimate and log-rank test.@*Results @#The 36
patients with
malignant mesothelioma included 6
men ( 16.67% ) and 30
women ( 83.33% ), and had a median age of 61 ( interquartile range, 14 ) years. There were 30 cases with pleural
malignant mesothelioma ( 83.33% ) and 6 cases with peritoneal
malignant mesothelioma ( 16.67% ), 32 cases ( 88.89% ) with a
history of
occupational exposure to
asbestos, and 26 cases ( 72.22% ) receiving
palliative treatment. The 1-, 2- and 3-year
cumulative survival rates were 30%, 15% and 3%, respectively, and the median
survival time was 0.71 years. In addition, there were no significant differences in the
survival period among
patients with
malignant mesothelioma in terms of
gender, age, route of
asbestos exposure, duration of
asbestos exposure, pathogenic site and
treatment regimens ( P>0.05 ).@*Conclusion @#The 36
patients with
malignant mesothelioma had a median
survival period of 0.71 years, and no
association was found between the
survival period and
asbestos exposure or pathogenic site.